About the Authors

Benjamin Rolland

benjamin.rolland@chru-lille.fr

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, Service d’Addictologie, CHU Lille, Univ Lille Nord de France, Lille, France

François Paille

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, Service d’Addictologie, CHU Nancy, Université, Univ Nancy, Nancy, France

Benoit Fleury

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, Service d'Hépatogastroentérologie et d'Alcoologie, CHU Bordeaux, Bordeaux, France

Olivier Cottencin

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, Service d’Addictologie, CHU Lille, Univ Lille Nord de France, Lille, France

Amine Benyamina

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, CERTA L’Albatros, Hôpital Paul Brousse, AP-HP, INSERM U 669, Villejuif, France

Henri-Jean Aubin

Affiliations Société Française d’Alcoologie, Issy-les-Moulineaux, France, CERTA L’Albatros, Hôpital Paul Brousse, AP-HP, INSERM U 669, Villejuif, France

Competing Interests

Dr ROLLAND is the main investigator in a clinical trial funded by ETHYPHARM, which is developing a labelled form of baclofen for alcohol use disorders. Dr PAILLE has received sponsorship to attend scientific meetings, speaker honoraria, and consultancy fees from Lundbeck, Ethypharm, D&A Pharma, and Merck-Serono. Dr FLEURY has received sponsorship to attend scientific meetings from Lundbeck. Dr COTTENCIN is an associate Investigator in the ALPADIR clinical trial, comparing HDB vs. placebo for abstinence maintenance, which is funded by ETHYPHARM. He has received sponsorship to attend scientific meetings from Lundbeck, BMS Otsuka, Janssen Cilag, Reckitt Benckiser, Pfizer, Bouchara Recordati. Dr BENYAMINA has received sponsorship to attend scientific meetings, speaker honoraria, and consultancy fees from Merck-Serono, BMS, Reckitt-Benckiser Pharma, and Otsuka. Dr Benyamina is a member of the Lundbeck scientific board in France for Selincro. Dr AUBIN has received sponsorship to attend scientific meetings, speaker honoraria, and consultancy fees from Bioprojet, D&A Pharma, Ethypharm, Lundbeck, Merck-Serono, Novartis, and Pfizer.

Author Contributions

Conceived and designed the experiments: BR FP BF HJA. Analyzed the data: BR FP HJA. Wrote the paper: BR FP BF OC AB HJA.